Tenderwize
Back to tender search

Open-house rebate agreement for Aclidiniumbromid

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 03, 2028 · 504 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aclidiniumbromid, ATC R03BB05

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

55 / 100

Complexity

48 / 100

Risk factors

Paper submissions must be sent in duplicate originals, and electronic submissions must use the DTVP communication area...

The notice limits participation to pharmaceutical companies and requires a signed declaration of reliability plus suppo...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2028
  • Non-exclusive pharmaceutical rebate agreement for the active substance Aclidiniumbromid (ATC R03BB05).
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Show full summary

This is an open-house pharmaceutical rebate agreement for Aclidiniumbromid (ATC R03BB05) led by AOK Bayern. It is not a competitive award procedure: all interested pharmaceutical companies meeting the stated eligibility conditions may join on identical, non-negotiable terms. The contract period runs from 01.03.2026 to 29.02.2028, with contract entry possible until 03.01.2028. Submission is via DTVP or by signed paper originals; German language is required, and non-German documents must include a German translation.

Risks

Paper submissions must be sent in duplicate originals, and electronic submissions must use the DTVP communication area...

The notice limits participation to pharmaceutical companies and requires a signed declaration of reliability plus suppo...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Aclidiniumbromid

Single lot open-house supply agreement for pharmaceutical rebate contracts concerning Aclidiniumbromid, ATC R03BB05. The lot is framework-like/open-house in nature, with no selection among bidders and identical contract terms for all eligible pharmaceutical companies. Performance is in Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2026 - Feb 2028

Category

Pharmaceutical products

Deadline

Deadline Jan 03, 2028

Procurement Details

Publication date
13 Jan 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
25404-2026

Documents (2)

Similar tenders